Sector | Agriculture | Compare with Sector peers |
Industry | Agriculture | Compare with Industry peers |
Website | http://www.indousagriseeds.com | |
Market Cap | 441.24 Cr. | |
Enterprise Value(EV) | 456.20 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 3.61 | Trailing Twelve Months Ending 2023-03 |
Price-Earning Ratio (PE) | 60.94 | Trailing Twelve Months Ending 2023-03 |
Industry PE | - | Trailing Twelve Months Ending 2023-03 |
Book Value / Share | 30.55 | Trailing Twelve Months Ending 2023-03 |
Price to Book Value | 7.20 | Calculated using Price: 220.05 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 2.01 Cr. | 20,052,000 Shares |
FaceValue | 10 | |
About Indo US Bio-Tech Ltd. | ||
The company is engaged in the business of breeding products, processing and marketing of high performing open-pollinated and hybrid agricultural seed varieties & (seed testing, soil & water testing). The company has its own laboratory for seed testing at Junagadh. In the initial stage, the company was engaged in producing different varieties of oilseeds and pulses seeds, later on, it also added vegetable, spices and cereals seeds to its basket. Its products are being marketed under various brands names like INDO-US 955, INDO-US 936, INDO-US 927 etc. It is 9001:2015 certified engaged in research plant, breeding products, processing and marketing of sales high performing open pollinated and hybrid agricultural seed varieties. Indo US Bio-Tech is a recognized seed importer from National Seeds Corporation Limited. |
1 Day |
|
-4.33% |
1 Week |
|
-8.31% |
1 Month |
|
+3.36% |
3 Month |
|
-10.37% |
6 Month |
|
+15.82% |
1 Year |
|
+88.88% |
2 Year |
|
+502.88% |
5 Year |
|
+469.19% |
10 Year |
|
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 19.83 | 11.69 | 11.74 | 34.36 | 22.21 | 16.74 | 26.87 | 17.34 | 15.51 | |
Return on Capital Employed (%) | 13.92 | 7.39 | 14.24 | 27.84 | 20.35 | 16.65 | 18.3 | 15.86 | 14.62 | |
Return on Assets (%) | 7.63 | 3.55 | 3.14 | 10.01 | 10.26 | 8.66 | 13.05 | 10.63 | 11.67 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 3 | 3 | 3 | 5 | 14 | 16 | 22 | 39 | 55 | 58 | |
Non Curr. Liab. | 0 | 0 | 0 | 1 | 1 | 2 | 4 | 4 | 2 | 4 | |
Curr. Liab. | 4 | 10 | 9 | 10 | 9 | 17 | 18 | 12 | 12 | 16 | |
Minority Int. | |||||||||||
Equity & Liab. | 7 | 13 | 12 | 17 | 24 | 35 | 43 | 55 | 69 | 78 | |
Non Curr. Assets | 1 | 1 | 1 | 2 | 3 | 3 | 5 | 8 | 9 | 11 | |
Curr. Assets | 6 | 12 | 11 | 15 | 21 | 32 | 38 | 47 | 60 | 67 | |
Misc. Exp. not W/O | 0 | 0 | 0 | ||||||||
Total Assets | 7 | 13 | 12 | 17 | 24 | 35 | 43 | 55 | 69 | 78 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Net Sales | 15 | 20 | 19 | 25 | 30 | 35 | 40 | 40 | 50 | 62 | |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Total Income | 15 | 20 | 19 | 25 | 30 | 36 | 40 | 40 | 50 | 62 | |
Total Expenditure | -14 | -19 | -19 | -23 | -27 | -32 | -36 | -35 | -43 | -52 | |
PBIDT | 0 | 1 | 1 | 1 | 3 | 3 | 4 | 6 | 7 | 9 | |
Interest | 0 | 0 | 0 | -1 | -1 | 0 | -1 | -1 | -1 | -1 | |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | |
Taxation | 0 | 0 | 0 | 0 | -1 | -1 | 0 | 1 | 0 | 0 | |
Exceptional Items | 0 | ||||||||||
PAT | 0 | 1 | 0 | 0 | 1 | 2 | 3 | 5 | 5 | 7 | |
Adjusted EPS | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 4 | 3 | 4 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | -3 | 0 | -1 | -3 | -1 | 0 | 3 | 1 | |
Cash Fr. Inv. | 0 | 0 | 0 | 0 | 0 | -3 | -1 | -2 | -5 | -7 | |
Cash Fr. Finan. | 0 | 0 | 3 | 0 | 1 | 6 | 2 | 1 | 2 | 6 | |
Net Change | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Mon, 15 Apr 2024
Compliances- Certificate Under Reg 40(9) Certificate Under Reg 40(9) of SEBI LODR for the year ended on 31-03-2024. |
Sat, 13 Apr 2024
Compliances- Compliance Certificate For The Period Ended March 2024 Compliance Certificate under Regulation 7(3) of SEBI LODR |
Tue, 09 Apr 2024
Response To Clarification On Price Movement Of Indo Us Bio Tech Limited (Scrip Id: INDOUS Scrip Code: 541304) - Regulation 30. Reply Letter |
Tue, 16 Apr 2024 |
High Delivery Percentage |
Opening at High |
Opening at High for 3 days |
Closing Below Previous Low |
Opening at High for 2 Days |